|5(6)-羧基荧光素二乙酸酯|CsnPharm

CAS No.: 124387-19-5

5(6)-CFDA/5(6)-羧基荧光素二乙酸酯 Catalog No. CSN10034

Synonyms: 5-(6)-Carboxyfluorescein diacetate;CFDA;5(6)-羧基荧光素二乙酸酯

5(6)-CFDA is a cell-permeant esterase substrate that can serve as a viability probe that measures both enzymatic activity, which is require to activate its fluorescence, and cell-membrane integrity, which is required for intracellular retention of their fluorescent product.

规格	价格	促销价格	库存	数量

400-920-2911

sales@csnpharm.cn

tech@csnpharm.cn

加入购物车大规格询价

加入收藏

产品咨询

400-920-2911

sales@csnpharm.cn

tech@csnpharm.cn

纯度 & 质量文件批次:

靶点选择性

生物活性

实验方案

技术信息

生物活性

描述5(6)-CFDA is a cell-permeant esterase substrate that can serve as a viability probe that measures both enzymatic activity, which is require to activate its fluorescence, and cell-membrane integrity, which is required for intracellular retention of their fluorescent product.
临床研究

NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点
NCT03449459	Chronic Obstructive Pulmonary ... more >>Disease (COPD) Collapse <<	Early Phase 1	Not yet recruiting	December 2020	China, Guangdong ... more >> The First Affiliated Hospital of Guangzhou Medical University Not yet recruiting Guangzhou, Guangdong, China Contact: Bing Yuan, PhD 020-83205181 506638016@qq.com China, Shanghai Ruijin Hospital, Shanghai Jiao Tong University Not yet recruiting Shanghai, Shanghai, China Contact: Ranran Dai, Master 021-34186000 drrcyy@msn.com Shanghai Zhongshan Hospital Not yet recruiting Shanghai, Shanghai, China Contact: Jing Zhang, MD,PhD 021-64041990 huxizhangjing@foxmail.com Contact: Jing Bi, Master 021-64041990 bi.jing@zs-hospital.sh.cn Collapse <<
NCT03621072	Bioequivalence	Phase 1	Not yet recruiting	May 2019	-
NCT03157726	Benign Prostatic Hyperplasia	Not Applicable	Recruiting	June 1, 2021	China, Guangdong ... more >> Zhujiang Hospital of Southern Medical University Recruiting Guangzhou, Guangdong, China, 510282 Contact: Shaobo SB Zheng, M.D +86-13602888356 1h1h1h864@sina.com Contact: ChunXiao CX Liu, M.D., Ph.D +86-13302296795 liuchx888@hotmail.com Collapse <<

更多
参考文献

[1] Yang T, Chen ZZ, et al. A novel nonradioactive CFDA assay to monitor the cellular immune response in myeloid leukemia. Immunobiology. 2013 Apr;218(4):548-53.
[2] Fang X, Zhao R, et al. Bone marrow-derived endothelial progenitor cells are involved in aneurysm repair in rabbits. J Clin Neurosci. 2012 Sep;19(9):1283-6.

实验方案

计算器摩尔计算器总药量计算器工作液计算器
储存液制备
- 1 mg
- 5 mg
- 10 mg
- 1 mM
- 2.1721 mL
- 10.8604 mL
- 21.7207 mL
- 5 mM
- 0.4344 mL
- 2.1721 mL
- 4.3441 mL
- 10 mM
- 0.2172 mL
- 1.0860 mL
- 2.1721 mL

技术信息

CAS号	124387-19-5	储存条件	粉末液体 -20°C:3-6 月 -80°C:12月
分子式	C25H16O9	运输	蓝冰
分子量	460.39	别名	5-(6)-Carboxyfluorescein diacetate;CFDA;5(6)-羧基荧光素二乙酸酯

大规格询价

号为必填项

姓名: 邮箱: 手机号:

留言:

提交

NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点

NCT03449459	Chronic Obstructive Pulmonary ... more >>Disease (COPD) Collapse <<	Early Phase 1	Not yet recruiting	December 2020	China, Guangdong ... more >> The First Affiliated Hospital of Guangzhou Medical University Not yet recruiting Guangzhou, Guangdong, China Contact: Bing Yuan, PhD 020-83205181 506638016@qq.com China, Shanghai Ruijin Hospital, Shanghai Jiao Tong University Not yet recruiting Shanghai, Shanghai, China Contact: Ranran Dai, Master 021-34186000 drrcyy@msn.com Shanghai Zhongshan Hospital Not yet recruiting Shanghai, Shanghai, China Contact: Jing Zhang, MD,PhD 021-64041990 huxizhangjing@foxmail.com Contact: Jing Bi, Master 021-64041990 bi.jing@zs-hospital.sh.cn Collapse <<
NCT03621072	Bioequivalence	Phase 1	Not yet recruiting	May 2019	-
NCT03157726	Benign Prostatic Hyperplasia	Not Applicable	Recruiting	June 1, 2021	China, Guangdong ... more >> Zhujiang Hospital of Southern Medical University Recruiting Guangzhou, Guangdong, China, 510282 Contact: Shaobo SB Zheng, M.D +86-13602888356 1h1h1h864@sina.com Contact: ChunXiao CX Liu, M.D., Ph.D +86-13302296795 liuchx888@hotmail.com Collapse <<
NCT02991872	Virus Diseases	Phase 4	Completed	-	China ... more >> GSK Investigational Site Mengshan, China, 546700 Collapse <<
NCT02810522	Blood Glucose Measurement	Not Applicable	Unknown	March 2017	-
NCT03282266	Pulmonary Arterial Hypertensio... more >>n Collapse <<	Not Applicable	Recruiting	July 30, 2021	China, Jiangsu ... more >> Nanjing First Hospital Recruiting Nanjing, Jiangsu, China, 210006 Contact: Shaoliang Chen, MD +86 13605157029 chmengx@126.com Contact: Hang zhang, MD +86 13951922158 dxh_nari@sina.com Collapse <<
NCT00856401	Hypoparathyroidism	Phase 3	Active, not recruiting	June 30, 2021	United States, New York ... more >> Columbia University Medical Center New York, New York, United States, 10032 Collapse <<
NCT03353480	Bioequivalence	Phase 1	Completed	-	China, Jilin ... more >> The First Hospital of Jilin University/Phase I Clinical Trials Unit Changchun, Jilin, China, 130021 Collapse <<

5(6)-CFDA/5(6)-羧基荧光素二乙酸酯 Catalog No. CSN10034

靶点选择性

请登录您的专属账户

确认信息